Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, April 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

patent: 36 patents
f1000: 1 research highlight platform

Readers on

mendeley: 272 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 3 posts from 1 blogs.

The Four Percent Lung Cancer Solution

Mission Tumor, 08 Jun 2011

A small group of lung cancer patients, who carry EML4-ALK marker in their tumor genome, can now look forward to a cancer-free…

The Four Percent Lung Cancer Solution

Mission Tumor, 08 Jun 2011

A small group of lung cancer patients, who carry EML4-ALK marker in their tumor genome, can now look forward to a cancer-free…

The Four Percent Lung Cancer Solution

Mission Tumor, 08 Jun 2011

A small group of lung cancer patients, who carry EML4-ALK marker in their tumor genome, can now look forward to a cancer-free…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.